ArticleJournal of experimental & clinical cancer research : CR2026
IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myeloma.
Hatice Satilmis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.